Autolus Therapeutics PLC (AUTL)
4.01
+0.02
(+0.50%)
USD |
NASDAQ |
May 13, 16:00
4.005
0.00 (0.00%)
After-Hours: 20:00
Autolus Therapeutics Total Return Level: 4.01 for May 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 13, 2024 | 4.01 |
May 10, 2024 | 3.99 |
May 09, 2024 | 4.17 |
May 08, 2024 | 4.11 |
May 07, 2024 | 4.01 |
May 06, 2024 | 4.08 |
May 03, 2024 | 4.19 |
May 02, 2024 | 4.11 |
May 01, 2024 | 4.00 |
April 30, 2024 | 3.68 |
April 29, 2024 | 3.80 |
April 26, 2024 | 4.00 |
April 25, 2024 | 4.08 |
April 24, 2024 | 4.21 |
April 23, 2024 | 4.48 |
April 22, 2024 | 4.56 |
April 19, 2024 | 4.52 |
April 18, 2024 | 4.80 |
April 17, 2024 | 4.84 |
April 16, 2024 | 4.86 |
April 15, 2024 | 4.90 |
April 12, 2024 | 5.02 |
April 11, 2024 | 5.33 |
April 10, 2024 | 5.15 |
April 09, 2024 | 5.43 |
Date | Value |
---|---|
April 08, 2024 | 5.43 |
April 05, 2024 | 5.60 |
April 04, 2024 | 5.51 |
April 03, 2024 | 5.49 |
April 02, 2024 | 5.51 |
April 01, 2024 | 5.68 |
March 28, 2024 | 6.38 |
March 27, 2024 | 6.24 |
March 26, 2024 | 6.17 |
March 25, 2024 | 6.33 |
March 22, 2024 | 6.32 |
March 21, 2024 | 6.25 |
March 20, 2024 | 6.55 |
March 19, 2024 | 6.20 |
March 18, 2024 | 6.205 |
March 15, 2024 | 5.82 |
March 14, 2024 | 5.70 |
March 13, 2024 | 5.48 |
March 12, 2024 | 5.39 |
March 11, 2024 | 5.41 |
March 08, 2024 | 5.71 |
March 07, 2024 | 5.39 |
March 06, 2024 | 5.66 |
March 05, 2024 | 5.70 |
March 04, 2024 | 5.79 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.64
Minimum
Apr 26 2023
23.90
Maximum
May 15 2019
7.003
Average
5.90
Median
Oct 07 2021
Total Return Level Benchmarks
Adaptimmune Therapeutics PLC | 1.17 |
Biodexa Pharmaceuticals Plc | 0.9685 |
NuCana PLC | 3.73 |
TC BioPharm (Holdings) PLC | 1.13 |
Mereo BioPharma Group PLC | 2.97 |